Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
07 Septembre 2022 - 1:21PM
Edgar (US Regulatory)
Filed Pursuant to Rule 433
Registration Statement 333-239720
ORIX Corporation
US$500,000,000 Fixed Rate Senior Debt Securities Due 2027
|
|
|
Issuer: |
|
ORIX Corporation |
|
|
Expected Security Ratings:* |
|
Moodys: A3 |
|
|
|
|
S&P: A- |
|
|
|
|
Fitch: A- |
|
|
Issuer Ratings:* |
|
Moodys: A3 (stable) |
|
|
|
|
S&P: A- (stable) |
|
|
|
|
Fitch: A- (stable) |
|
|
Format: |
|
SEC Registered |
|
|
Security Type: |
|
Senior Debt Securities |
|
|
Ranking: |
|
Direct, unsecured and unsubordinated general obligations of the issuer |
|
|
Currency: |
|
USD |
|
|
Size: |
|
US$500,000,000 |
|
|
Coupon: |
|
5.00%, Fixed Rate |
|
|
Net Proceeds before Expenses: |
|
US$497,355,000 |
|
|
Trade Date: |
|
September 6, 2022 |
|
|
Settlement Date: |
|
September 13, 2022 (T+5) |
|
|
Maturity: |
|
September 13, 2027 |
|
|
Coupon Payment Dates: |
|
March 13 and September 13 of each year, beginning on March 13, 2023 |
|
|
Day Count Convention: |
|
30/360 (unadjusted) |
|
|
Pricing Benchmark: |
|
3.125% due August 31, 2027 |
|
|
Benchmark Spot (Price/Yield): |
|
98-18 / 3.441% |
|
|
Spread to Benchmark: |
|
T5+160bps |
|
|
Issue Price: |
|
99.821% of the principal amount |
|
|
Yield: |
|
5.041% |
|
|
Business Days: |
|
New York, Tokyo |
|
|
Minimum Denominations: |
|
US$2,000 and integral multiples of US$1,000 in excess thereof |
|
|
Listing: |
|
None |
|
|
Billing & Delivering: |
|
Morgan Stanley & Co. LLC |
|
|
Joint Bookrunners: |
|
Morgan Stanley & Co. LLC |
|
|
|
|
Goldman Sachs & Co. LLC |
|
|
|
|
J.P. Morgan Securities LLC |
|
|
|
|
BofA Securities, Inc. |
|
|
|
|
Citigroup Global Markets Inc. |
|
|
|
Co-Managers**: |
|
Australia and New Zealand Banking Group Limited |
|
|
|
|
BNP Paribas |
|
|
|
|
Crédit Agricole Corporate and Investment Bank |
|
|
|
|
Daiwa Capital Markets America Inc. |
|
|
|
|
Deutsche Bank Securities Inc. |
|
|
|
|
Mizuho Securities USA LLC |
|
|
|
|
Nomura Securities International, Inc. |
|
|
CUSIP: |
|
686330 AQ4 |
|
|
ISIN: |
|
US686330AQ49 |
|
|
Common Code: |
|
252855165 |
|
|
|
* Note: |
|
A security rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time by the assigning rating agencies. |
** |
|
One or more of the underwriters may not be U.S.-registered broker-dealers. All sales of securities in the United States will be made by or through U.S.-registered broker-dealers, which may include affiliates of one or more of
the underwriters. |
This communication is intended for the sole use of the person to whom it is provided by us. This communication does not
constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.
The issuer has filed a registration statement (including a base prospectus) and a preliminary prospectus supplement (together with the base prospectus, the
prospectus) with the U.S. Securities and Exchange Commission, or the SEC, for the offering to which this communication relates. Before you invest, you should read the prospectus and other documents the issuer has filed with the SEC for
more complete information about the issuer and this offering. You may obtain these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will
arrange to send you the prospectus, if you request it by calling Morgan Stanley & Co. LLC toll-free at 1-866-718-1649,
Goldman Sachs & Co. LLC at 1-212-902-1171 (Prospectus Department), J.P. Morgan Securities LLC collect at 1-212-834-4533, BofA Securities, Inc. toll-free at 1-800-294-1322 or Citigroup Global Markets Inc. toll-free at 1-800-831-9146.
No PRIIPs KID - No PRIIPs key information document (KID) has been prepared as not available to retail in EEA or U.K. See Prohibition of
Sales to EEA Retail Investors and Prohibition of Sales to U.K. Retail Investors in the prospectus.
ORIX Corporation
US$500,000,000 Fixed Rate Senior Debt Securities Due 2032
|
|
|
Issuer: |
|
ORIX Corporation |
|
|
Expected Security Ratings:* |
|
Moodys: A3 |
|
|
|
|
S&P: A- |
|
|
|
|
Fitch: A- |
|
|
Issuer Ratings:* |
|
Moodys: A3 (stable) |
|
|
|
|
S&P: A- (stable) |
|
|
|
|
Fitch: A- (stable) |
|
|
Format: |
|
SEC Registered |
|
|
Security Type: |
|
Senior Debt Securities |
|
|
Ranking: |
|
Direct, unsecured and unsubordinated general obligations of the issuer |
|
|
Currency: |
|
USD |
|
|
Size: |
|
US$500,000,000 |
|
|
Coupon: |
|
5.20%, Fixed Rate |
|
|
Net Proceeds before Expenses: |
|
US$496,285,000 |
|
|
Trade Date: |
|
September 6, 2022 |
|
|
Settlement Date: |
|
September 13, 2022 (T+5) |
|
|
Maturity: |
|
September 13, 2032 |
|
|
Coupon Payment Dates: |
|
March 13 and September 13 of each year, beginning on March 13, 2023 |
|
|
Day Count Convention: |
|
30/360 (unadjusted) |
|
|
Pricing Benchmark: |
|
2.750% due August 15, 2032 |
|
|
Benchmark Spot (Price/Yield): |
|
95-02 / 3.338% |
|
|
Spread to Benchmark: |
|
T10+190bps |
|
|
Issue Price: |
|
99.707% of the principal amount |
|
|
Yield: |
|
5.238% |
|
|
Business Days: |
|
New York, Tokyo |
|
|
Minimum Denominations: |
|
US$2,000 and integral multiples of US$1,000 in excess thereof |
|
|
Listing: |
|
None |
|
|
Billing & Delivering: |
|
Morgan Stanley & Co. LLC |
|
|
Joint Bookrunners: |
|
Morgan Stanley & Co. LLC |
|
|
|
|
Goldman Sachs & Co. LLC |
|
|
|
|
J.P. Morgan Securities LLC |
|
|
|
|
BofA Securities, Inc. |
|
|
|
|
Citigroup Global Markets Inc. |
|
|
|
|
|
Co-Managers**: |
|
Australia and New Zealand Banking Group Limited |
|
|
|
|
BNP Paribas |
|
|
|
|
Crédit Agricole Corporate and Investment Bank |
|
|
|
|
Daiwa Capital Markets America Inc. |
|
|
|
|
Deutsche Bank Securities Inc. |
|
|
|
|
Mizuho Securities USA LLC |
|
|
|
|
Nomura Securities International, Inc. |
|
|
CUSIP: |
|
686330 AR2 |
|
|
ISIN: |
|
US686330AR22 |
|
|
Common Code: |
|
252855416 |
|
|
|
* Note: |
|
A security rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time by the assigning rating agencies. |
** |
|
One or more of the underwriters may not be U.S.-registered broker-dealers. All sales of securities in the United States will be made by or through U.S.-registered broker-dealers, which may include affiliates of one or more of
the underwriters. |
This communication is intended for the sole use of the person to whom it is provided by us. This communication does not
constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.
The issuer has filed a registration statement (including a base prospectus) and a preliminary prospectus supplement (together with the base prospectus, the
prospectus) with the U.S. Securities and Exchange Commission, or the SEC, for the offering to which this communication relates. Before you invest, you should read the prospectus and other documents the issuer has filed with the SEC for
more complete information about the issuer and this offering. You may obtain these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will
arrange to send you the prospectus, if you request it by calling Morgan Stanley & Co. LLC toll-free at 1-866-718-1649,
Goldman Sachs & Co. LLC at 1-212-902-1171 (Prospectus Department), J.P. Morgan Securities LLC collect at 1-212-834-4533, BofA Securities, Inc. toll-free at 1-800-294-1322 or Citigroup Global Markets Inc. toll-free at 1-800-831-9146.
No PRIIPs KID - No PRIIPs key information document (KID) has been prepared as not available to retail in EEA or U.K. See Prohibition of
Sales to EEA Retail Investors and Prohibition of Sales to U.K. Retail Investors in the prospectus.
Orix (NYSE:IX)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Orix (NYSE:IX)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025